Nextpower Inc. ( NXT ), formerly Nextracker, closed near $84.50 in early September 2026, roughly 77% below the $150 level investors are asking about. Wall Street consensus remains a Strong Buy, with an average 12-month price target near $141.52 and a handful of estimates extending to $180 or higher.

Robert Half (RHI) shares traded near $41 in early September 2026, down roughly 4% from about $42.74 a month earlier, keeping the stock in a tight range after a volatile summer. Second-quarter 2026 revenue of $1.336 billion fell 2% year over year, while diluted EPS of $0.26 declined from $0.41 in the prior-year period.

MMED closed at $23.29 on September 4, down -2.31% (-$0.55) from the prior session's $23.84 close during regular trading hours. The primary catalyst was the completed ~$805 million public offering of common stock, which triggered investor concerns over share dilution and a sharply larger share count.

ELF closed up +2.10% (+$2.26) at $109.67 in regular trading, versus a $107.41 prior close. No single company-specific catalyst on the day; the advance extended strong momentum after strong Q1 FY2027 results and raised guidance.

RingCentral (RNG) shares climbed roughly 19% over the trailing 30 days, advancing from about $61 in early August to $73.39, extending a rally that has carried the stock near multi-year highs. The move reflects continued momentum following a second-quarter 2026 earnings beat, with revenue of $657 million and non-GAAP EPS of $1.22 both exceeding consensus estimates.

Warrior Met Coal (HCC) climbed roughly 13.6% over the last 30 days, from about $91.97 in early August to near $104.45 by early September. The move followed a strong second-quarter 2026 report featuring record sales volumes, sharply higher earnings, and more than $103 million in free cash flow.

Data center entry is the defining catalyst. Two custom-silicon engagements with hyperscalers begin generating revenue in the December 2026 quarter, with management targeting $5 billion in data center revenue by fiscal 2027 and more than $15 billion by fiscal 2029. Non-handset diversification is accelerating. Qualcomm doubled its fiscal 2029 non-handset revenue target to $40 billion, with automotive and IoT (Internet of Things) combined with data center expected to become roughly two-thirds of its chip business.

Selected price target: $180 per share, roughly 18% above the recent trading level and in line with the upper end of Wall Street's published price objectives. Bullish factors: A "Buy" consensus rating, recent upgrades from major banks, improving earnings estimates, and a recovery in enterprise IT spending.

The selected target is $30 , a level that sits above Coeur Mining's 52-week high of $27.77 and implies an advance of roughly 40% from recent prices near $21. Strongest bullish factors include elevated gold and silver prices, the completed all-share acquisition of New Gold, and a growing, diversified mine portfolio across the U.S., Canada, and Mexico.

Royal Gold (RGLD) shares rose approximately 21.9% over the last 30 days, from a close of $215.09 on August 5 to $262.11 as of the most recent session. The advance extended a broader recovery that began after the stock bottomed near $187 in mid-July, marking a gain of roughly 40% from that trough.

CRCL recently traded near $102, putting the $140 target roughly 37% above current levels. The $140 objective aligns with Bernstein's published price target and sits just below the stock's 52-week high of $159.47.

The target: Investors are asking whether Super Micro Computer, Inc. (SMCI) can climb back to the psychologically important $50 level, roughly 30% above its recent trading range near $38. Bull case: A record backlog, more than $60 billion in new orders, and fiscal 2027 revenue guidance of $65 billion to $72 billion support a stronger valuation.

Insmed shares trade near $126, roughly 3%–4% lower over the trailing 30 days following a sharp post-earnings surge in early August. BRINSUPRI (brensocatib), the first and only FDA-approved treatment for non-cystic fibrosis bronchiectasis (NCFB), remains the company's central growth engine.

Datadog shares fell roughly 24.8% over the 30-day window, from a closing price near $283.17 to about $212.93, driven primarily by a sharp post-earnings selloff. The decline followed an otherwise strong Q2 2026 report: revenue rose 36% year over year to $1.12 billion, and the company raised its full-year outlook.

Fabrinet (FN) shares declined roughly 22% over the 30 days through early September 2026, falling from about $522 to near $407. The selloff accelerated after the stock touched an intraday high near $603 in mid-August before reversing sharply lower.

MRNY climbed roughly 157% over the past 30 days, from about $14.36 to $36.97, almost entirely because of a single-session breakout in Moderna ( MRNA ). The catalyst was positive Phase 3 results for Moderna and Merck's personalized mRNA cancer vaccine in high-risk melanoma, a first for the class.

CRCG is a single-stock leveraged exchange-traded fund (ETF) that seeks to deliver twice (2x) the daily return of Circle Internet Group (CRCL), the issuer of the USD Coin (USDC) stablecoin. The fund has gained roughly 105% over the trailing 30 days, recovering from its late-July and early-August lows.

BMNU surged roughly +81% over the trailing 30 days, driven by a sharp late-summer rally in digital assets that lifted its sole underlying exposure. The fund seeks 200% daily (2x) leveraged exposure to Bitmine Immersion Technologies (NYSE: BMNR), amplifying both the stock's gains and its losses.

ETHT, a 2x daily leveraged Ether (Ethereum) fund, rose roughly 58% over the last 30 days, tracking one of Ether's sharpest rallies of the year. Over the trailing quarter, ETHT gained about 66% , though the path was exceptionally volatile, with a 52-week low near $7 in late June preceding the rebound.

SNXX climbed roughly 47% over the last 30 days, rising from about $9.34 to $13.71 per share. Over the trailing three months, however, the fund is down approximately 54%, reflecting a sharp mid-2026 drawdown followed by only a partial rebound.